Changes in recommendations about amoxycillin prophylaxis for prevention of endocarditis [9]

Lancet

Volumn 350, Issue 9084, 1997, Pages 1100-

  Littler, W A ^a   McGowan, D A ^a   Shanson, D C ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; LIDOCAINE; LOCAL ANESTHETIC AGENT;

ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC SENSITIVITY; BACTERIAL ENDOCARDITIS; DENTIST; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SOLUBILITY; EUROPE; HEALTH CARE AVAILABILITY; HUMAN; INJECTION PAIN; INTRAVENOUS DRUG ADMINISTRATION; LETTER; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRECIPITATION; PRIORITY JOURNAL; RISK FACTOR; UNITED KINGDOM; UNITED STATES;

EID: 0030868134     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)26041-1     Document Type: Letter

References (5)

1. Prevention of Bacterial Endocarditis Recommendations of the American Heart Association JAMA 277 1997 1794 1801
2. Dajani AS Bawdon RE Berry MC Oral amoxycillin prophylaxis for endocarditis: what is the optimal dose? Clin Infect Dis 18 1994 157 160
3. Shanson DC Cannon P Wilks M Amoxycillin compared with penicillin V for the prophylaxis of dental bacteraemia J Anttimicrob Chemother 4 1978 431 436
4. Littner MM Kaffe T Tamse A Buckner A New concept on chemoprophylaxis of bacterial endocarditis resulting from dental treatment Oral Surg Oral Med Oral Path 61 1986 338 342
5. British Society for Antimicrobial Chemotherapy Working Party Report. The antibiotic prophylaxis of infective endocarditis Lancet ii 1982 1323 1326